Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:16 AM
Ignite Modification Date:
2025-12-25 @ 2:16 AM
NCT ID:
NCT04143360
Eligibility Criteria:
The selection criteria were as follows:
* age 18-70 years, gender is not limited;
* subjects clearly understand the purpose of the study, are willing and able to comply with the requirements to complete the study and sign the informed consent;
* 18 Kg/m2 \< BMI \< 25 Kg/m2;
* patients who need thoracic closed drainage for exhaust and drainage because of pneumothorax volume \> 30%;
* subjects did not have serious chest wall deformities.
Exclusion criteria:
* Patients at high risk of bleeding, including patients with congenital hemophilia, thrombocytopenia (PLT \< 50 \*109/L), platelet dysfunction (such as idiopathic thrombocytopenic purpura, disseminated intravascular coagulation, congenital platelet dysfunction);
* Cardiopulmonary function is poor, which is not suitable for the participants.
* Patients with other infectious diseases (inflammation, tuberculosis) or empyema in the thoracic cavity;
* Infection of skin around puncture and drainage;
* Participated in other clinical trials within 30 days;
* Other reasons why the researchers think it is inappropriate to participate in the experiment.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
70 Years
Study:
NCT04143360
Study Brief:
Protocol Section:
NCT04143360